A coalition to heal-the impact of the cardiac microenvironment

Eldad Tzahor1, Stefanie Dimmeler2,3,4

  • 1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.

Science (New York, N.Y.)
|September 1, 2022
PubMed

Insights

Heart regenerative medicine explores cellular communication for cardiac repair. Therapies now target the cardiac microenvironment, focusing on inflammation and fibrosis for disease reversion beyond cardiomyocyte renewal.

Area of Science:

  • Cardiovascular Biology
  • Regenerative Medicine
  • Cardiac Microenvironment Research

Background:

  • The heart was historically viewed as non-regenerative due to terminally differentiated cardiomyocytes.
  • Understanding cardiac homeostasis and injury response reveals the importance of intercellular communication.
  • Recent advancements challenge this view, introducing novel therapeutic strategies.

Purpose of the Study:

  • To review the evolving field of heart regenerative medicine.
  • To discuss the significance of cellular cross-talk within the cardiac microenvironment.
  • To highlight emerging therapies targeting pathological cardiac conditions.

Main Methods:

  • Review of current literature on cardiac regenerative medicine.
  • Analysis of studies focusing on cellular communication in the heart.
  • Examination of therapies targeting the cardiac microenvironment, including matrix, vascular, and immune systems.

Main Results:

  • The heart is increasingly recognized as a dynamic organ with regenerative potential.
  • Cellular communication among all cardiac cell types is crucial for therapeutic strategies.
  • New approaches include cardiomyocyte renewal, matrix modification, vascularization, and immunomodulation.

Conclusions:

  • Targeting the cardiac microenvironment offers promising therapeutic avenues for heart disease.
  • Understanding and manipulating intercellular communication is key to advancing heart regeneration.
  • Future treatments will likely involve multi-targeted approaches to reverse cardiac pathology.